Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market 2023 by Company, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) market size and forecasts, in consumption value ($ Million), 2018-2029
Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lonza, Catalent, Patheon (Thermo Fisher Scientific), Aenova and Siegfried, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization), with revenue, gross margin and global market share of Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) from 2018 to 2023.
Chapter 3, the Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization).
Chapter 13, to describe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) research findings and conclusion.
This report is a detailed and comprehensive analysis for global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) market size and forecasts, in consumption value ($ Million), 2018-2029
Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lonza, Catalent, Patheon (Thermo Fisher Scientific), Aenova and Siegfried, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Intermediate CDMO
- API CDMO
- Formulation CDMO
- Protein CDMO
- Gene Therapy CDMO
- Cell Therapy CDMO
- Pharmaceutical Company
- Biotechnology Company
- Generic Company
- Others
- Lonza
- Catalent
- Patheon (Thermo Fisher Scientific)
- Aenova
- Siegfried
- Recipharm
- Strides Shasun
- Piramal
- Metrics
- AMRI
- Famar
- WuXi AppTech
- Asymchem
- Porton
- Amatsigroup
- AcuraBio
- Moravek
- Ascendia Pharmaceuticals
- Ardena
- CPL
- Arranta Bio
- UPM Pharmaceuticals
- FUJIFILM Diosynth Biotechnologies
- Groupe Parima
- TBD Pharmatech
- Avid Bioservices
- Vetter Pharma
- NextPharma
- Alcami
- NerPharMa
- Vetio
- Societal CDMO
- ten23 health
- Piramal Pharma Solutions
- MedPharm
- Lundbeck
- AGC Pharma Chemicals
- BioVectra
- Pfizer CentreOne
- Jubilant Biosys
- SEIKAGAKU CORPORATION
- Mikart
- Adare Pharma Solutions
- Fermion
- Samsung Biologics
- Siegfried Holdings
- Boehringer Ingelheim
- Jubilant Pharmova Limited
- Fareva SA
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization), with revenue, gross margin and global market share of Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) from 2018 to 2023.
Chapter 3, the Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization).
Chapter 13, to describe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization)
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) by Type
1.3.1 Overview: Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value Market Share by Type in 2022
1.3.3 Intermediate CDMO
1.3.4 API CDMO
1.3.5 Formulation CDMO
1.3.6 Protein CDMO
1.3.7 Gene Therapy CDMO
1.3.8 Cell Therapy CDMO
1.4 Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market by Application
1.4.1 Overview: Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Pharmaceutical Company
1.4.3 Biotechnology Company
1.4.4 Generic Company
1.4.5 Others
1.5 Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size & Forecast
1.6 Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size and Forecast by Region
1.6.1 Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Region, (2018-2029)
1.6.3 North America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size and Prospect (2018-2029)
1.6.4 Europe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size and Prospect (2018-2029)
1.6.6 South America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Lonza
2.1.1 Lonza Details
2.1.2 Lonza Major Business
2.1.3 Lonza Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
2.1.4 Lonza Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Lonza Recent Developments and Future Plans
2.2 Catalent
2.2.1 Catalent Details
2.2.2 Catalent Major Business
2.2.3 Catalent Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
2.2.4 Catalent Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Catalent Recent Developments and Future Plans
2.3 Patheon (Thermo Fisher Scientific)
2.3.1 Patheon (Thermo Fisher Scientific) Details
2.3.2 Patheon (Thermo Fisher Scientific) Major Business
2.3.3 Patheon (Thermo Fisher Scientific) Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
2.3.4 Patheon (Thermo Fisher Scientific) Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Patheon (Thermo Fisher Scientific) Recent Developments and Future Plans
2.4 Aenova
2.4.1 Aenova Details
2.4.2 Aenova Major Business
2.4.3 Aenova Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
2.4.4 Aenova Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Aenova Recent Developments and Future Plans
2.5 Siegfried
2.5.1 Siegfried Details
2.5.2 Siegfried Major Business
2.5.3 Siegfried Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
2.5.4 Siegfried Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Siegfried Recent Developments and Future Plans
2.6 Recipharm
2.6.1 Recipharm Details
2.6.2 Recipharm Major Business
2.6.3 Recipharm Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
2.6.4 Recipharm Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Recipharm Recent Developments and Future Plans
2.7 Strides Shasun
2.7.1 Strides Shasun Details
2.7.2 Strides Shasun Major Business
2.7.3 Strides Shasun Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
2.7.4 Strides Shasun Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Strides Shasun Recent Developments and Future Plans
2.8 Piramal
2.8.1 Piramal Details
2.8.2 Piramal Major Business
2.8.3 Piramal Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
2.8.4 Piramal Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Piramal Recent Developments and Future Plans
2.9 Metrics
2.9.1 Metrics Details
2.9.2 Metrics Major Business
2.9.3 Metrics Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
2.9.4 Metrics Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Metrics Recent Developments and Future Plans
2.10 AMRI
2.10.1 AMRI Details
2.10.2 AMRI Major Business
2.10.3 AMRI Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
2.10.4 AMRI Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 AMRI Recent Developments and Future Plans
2.11 Famar
2.11.1 Famar Details
2.11.2 Famar Major Business
2.11.3 Famar Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
2.11.4 Famar Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Famar Recent Developments and Future Plans
2.12 WuXi AppTech
2.12.1 WuXi AppTech Details
2.12.2 WuXi AppTech Major Business
2.12.3 WuXi AppTech Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
2.12.4 WuXi AppTech Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 WuXi AppTech Recent Developments and Future Plans
2.13 Asymchem
2.13.1 Asymchem Details
2.13.2 Asymchem Major Business
2.13.3 Asymchem Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
2.13.4 Asymchem Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Asymchem Recent Developments and Future Plans
2.14 Porton
2.14.1 Porton Details
2.14.2 Porton Major Business
2.14.3 Porton Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
2.14.4 Porton Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Porton Recent Developments and Future Plans
2.15 Amatsigroup
2.15.1 Amatsigroup Details
2.15.2 Amatsigroup Major Business
2.15.3 Amatsigroup Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
2.15.4 Amatsigroup Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Amatsigroup Recent Developments and Future Plans
2.16 AcuraBio
2.16.1 AcuraBio Details
2.16.2 AcuraBio Major Business
2.16.3 AcuraBio Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
2.16.4 AcuraBio Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 AcuraBio Recent Developments and Future Plans
2.17 Moravek
2.17.1 Moravek Details
2.17.2 Moravek Major Business
2.17.3 Moravek Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
2.17.4 Moravek Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Moravek Recent Developments and Future Plans
2.18 Ascendia Pharmaceuticals
2.18.1 Ascendia Pharmaceuticals Details
2.18.2 Ascendia Pharmaceuticals Major Business
2.18.3 Ascendia Pharmaceuticals Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
2.18.4 Ascendia Pharmaceuticals Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Ascendia Pharmaceuticals Recent Developments and Future Plans
2.19 Ardena
2.19.1 Ardena Details
2.19.2 Ardena Major Business
2.19.3 Ardena Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
2.19.4 Ardena Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 Ardena Recent Developments and Future Plans
2.20 CPL
2.20.1 CPL Details
2.20.2 CPL Major Business
2.20.3 CPL Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
2.20.4 CPL Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
2.20.5 CPL Recent Developments and Future Plans
2.21 Arranta Bio
2.21.1 Arranta Bio Details
2.21.2 Arranta Bio Major Business
2.21.3 Arranta Bio Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
2.21.4 Arranta Bio Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
2.21.5 Arranta Bio Recent Developments and Future Plans
2.22 UPM Pharmaceuticals
2.22.1 UPM Pharmaceuticals Details
2.22.2 UPM Pharmaceuticals Major Business
2.22.3 UPM Pharmaceuticals Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
2.22.4 UPM Pharmaceuticals Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
2.22.5 UPM Pharmaceuticals Recent Developments and Future Plans
2.23 FUJIFILM Diosynth Biotechnologies
2.23.1 FUJIFILM Diosynth Biotechnologies Details
2.23.2 FUJIFILM Diosynth Biotechnologies Major Business
2.23.3 FUJIFILM Diosynth Biotechnologies Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
2.23.4 FUJIFILM Diosynth Biotechnologies Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
2.23.5 FUJIFILM Diosynth Biotechnologies Recent Developments and Future Plans
2.24 Groupe Parima
2.24.1 Groupe Parima Details
2.24.2 Groupe Parima Major Business
2.24.3 Groupe Parima Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
2.24.4 Groupe Parima Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
2.24.5 Groupe Parima Recent Developments and Future Plans
2.25 TBD Pharmatech
2.25.1 TBD Pharmatech Details
2.25.2 TBD Pharmatech Major Business
2.25.3 TBD Pharmatech Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
2.25.4 TBD Pharmatech Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
2.25.5 TBD Pharmatech Recent Developments and Future Plans
2.26 Avid Bioservices
2.26.1 Avid Bioservices Details
2.26.2 Avid Bioservices Major Business
2.26.3 Avid Bioservices Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
2.26.4 Avid Bioservices Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
2.26.5 Avid Bioservices Recent Developments and Future Plans
2.27 Vetter Pharma
2.27.1 Vetter Pharma Details
2.27.2 Vetter Pharma Major Business
2.27.3 Vetter Pharma Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
2.27.4 Vetter Pharma Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
2.27.5 Vetter Pharma Recent Developments and Future Plans
2.28 NextPharma
2.28.1 NextPharma Details
2.28.2 NextPharma Major Business
2.28.3 NextPharma Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
2.28.4 NextPharma Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
2.28.5 NextPharma Recent Developments and Future Plans
2.29 Alcami
2.29.1 Alcami Details
2.29.2 Alcami Major Business
2.29.3 Alcami Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
2.29.4 Alcami Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
2.29.5 Alcami Recent Developments and Future Plans
2.30 NerPharMa
2.30.1 NerPharMa Details
2.30.2 NerPharMa Major Business
2.30.3 NerPharMa Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
2.30.4 NerPharMa Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
2.30.5 NerPharMa Recent Developments and Future Plans
2.31 Vetio
2.31.1 Vetio Details
2.31.2 Vetio Major Business
2.31.3 Vetio Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
2.31.4 Vetio Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
2.31.5 Vetio Recent Developments and Future Plans
2.32 Societal CDMO
2.32.1 Societal CDMO Details
2.32.2 Societal CDMO Major Business
2.32.3 Societal CDMO Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
2.32.4 Societal CDMO Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
2.32.5 Societal CDMO Recent Developments and Future Plans
2.33 ten23 health
2.33.1 ten23 health Details
2.33.2 ten23 health Major Business
2.33.3 ten23 health Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
2.33.4 ten23 health Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
2.33.5 ten23 health Recent Developments and Future Plans
2.34 Piramal Pharma Solutions
2.34.1 Piramal Pharma Solutions Details
2.34.2 Piramal Pharma Solutions Major Business
2.34.3 Piramal Pharma Solutions Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
2.34.4 Piramal Pharma Solutions Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
2.34.5 Piramal Pharma Solutions Recent Developments and Future Plans
2.35 MedPharm
2.35.1 MedPharm Details
2.35.2 MedPharm Major Business
2.35.3 MedPharm Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
2.35.4 MedPharm Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
2.35.5 MedPharm Recent Developments and Future Plans
2.36 Lundbeck
2.36.1 Lundbeck Details
2.36.2 Lundbeck Major Business
2.36.3 Lundbeck Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
2.36.4 Lundbeck Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
2.36.5 Lundbeck Recent Developments and Future Plans
2.37 AGC Pharma Chemicals
2.37.1 AGC Pharma Chemicals Details
2.37.2 AGC Pharma Chemicals Major Business
2.37.3 AGC Pharma Chemicals Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
2.37.4 AGC Pharma Chemicals Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
2.37.5 AGC Pharma Chemicals Recent Developments and Future Plans
2.38 BioVectra
2.38.1 BioVectra Details
2.38.2 BioVectra Major Business
2.38.3 BioVectra Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
2.38.4 BioVectra Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
2.38.5 BioVectra Recent Developments and Future Plans
2.39 Pfizer CentreOne
2.39.1 Pfizer CentreOne Details
2.39.2 Pfizer CentreOne Major Business
2.39.3 Pfizer CentreOne Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
2.39.4 Pfizer CentreOne Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
2.39.5 Pfizer CentreOne Recent Developments and Future Plans
2.40 Jubilant Biosys
2.40.1 Jubilant Biosys Details
2.40.2 Jubilant Biosys Major Business
2.40.3 Jubilant Biosys Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
2.40.4 Jubilant Biosys Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
2.40.5 Jubilant Biosys Recent Developments and Future Plans
2.41 SEIKAGAKU CORPORATION
2.42 Mikart
2.43 Adare Pharma Solutions
2.44 Fermion
2.45 Samsung Biologics
2.46 Siegfried Holdings
2.47 Boehringer Ingelheim
2.48 Jubilant Pharmova Limited
2.49 Fareva SA
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) by Company Revenue
3.2.2 Top 3 Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Players Market Share in 2022
3.2.3 Top 6 Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Players Market Share in 2022
3.3 Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market: Overall Company Footprint Analysis
3.3.1 Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market: Region Footprint
3.3.2 Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market: Company Product Type Footprint
3.3.3 Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value and Market Share by Type (2018-2023)
4.2 Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value Market Share by Application (2018-2023)
5.2 Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Type (2018-2029)
6.2 North America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Application (2018-2029)
6.3 North America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Country
6.3.1 North America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Country (2018-2029)
6.3.2 United States Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size and Forecast (2018-2029)
6.3.3 Canada Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size and Forecast (2018-2029)
6.3.4 Mexico Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Type (2018-2029)
7.2 Europe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Application (2018-2029)
7.3 Europe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Country
7.3.1 Europe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Country (2018-2029)
7.3.2 Germany Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size and Forecast (2018-2029)
7.3.3 France Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size and Forecast (2018-2029)
7.3.5 Russia Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size and Forecast (2018-2029)
7.3.6 Italy Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Region
8.3.1 Asia-Pacific Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Region (2018-2029)
8.3.2 China Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size and Forecast (2018-2029)
8.3.3 Japan Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size and Forecast (2018-2029)
8.3.4 South Korea Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size and Forecast (2018-2029)
8.3.5 India Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size and Forecast (2018-2029)
8.3.7 Australia Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Type (2018-2029)
9.2 South America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Application (2018-2029)
9.3 South America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Country
9.3.1 South America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Country (2018-2029)
9.3.2 Brazil Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size and Forecast (2018-2029)
9.3.3 Argentina Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Country
10.3.1 Middle East & Africa Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Country (2018-2029)
10.3.2 Turkey Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size and Forecast (2018-2029)
10.3.4 UAE Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Drivers
11.2 Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Restraints
11.3 Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Pharmaceutical CDMO (Phar
1.1 Product Overview and Scope of Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization)
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) by Type
1.3.1 Overview: Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value Market Share by Type in 2022
1.3.3 Intermediate CDMO
1.3.4 API CDMO
1.3.5 Formulation CDMO
1.3.6 Protein CDMO
1.3.7 Gene Therapy CDMO
1.3.8 Cell Therapy CDMO
1.4 Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market by Application
1.4.1 Overview: Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Pharmaceutical Company
1.4.3 Biotechnology Company
1.4.4 Generic Company
1.4.5 Others
1.5 Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size & Forecast
1.6 Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size and Forecast by Region
1.6.1 Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Region, (2018-2029)
1.6.3 North America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size and Prospect (2018-2029)
1.6.4 Europe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size and Prospect (2018-2029)
1.6.6 South America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Lonza
2.1.1 Lonza Details
2.1.2 Lonza Major Business
2.1.3 Lonza Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
2.1.4 Lonza Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Lonza Recent Developments and Future Plans
2.2 Catalent
2.2.1 Catalent Details
2.2.2 Catalent Major Business
2.2.3 Catalent Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
2.2.4 Catalent Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Catalent Recent Developments and Future Plans
2.3 Patheon (Thermo Fisher Scientific)
2.3.1 Patheon (Thermo Fisher Scientific) Details
2.3.2 Patheon (Thermo Fisher Scientific) Major Business
2.3.3 Patheon (Thermo Fisher Scientific) Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
2.3.4 Patheon (Thermo Fisher Scientific) Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Patheon (Thermo Fisher Scientific) Recent Developments and Future Plans
2.4 Aenova
2.4.1 Aenova Details
2.4.2 Aenova Major Business
2.4.3 Aenova Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
2.4.4 Aenova Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Aenova Recent Developments and Future Plans
2.5 Siegfried
2.5.1 Siegfried Details
2.5.2 Siegfried Major Business
2.5.3 Siegfried Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
2.5.4 Siegfried Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Siegfried Recent Developments and Future Plans
2.6 Recipharm
2.6.1 Recipharm Details
2.6.2 Recipharm Major Business
2.6.3 Recipharm Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
2.6.4 Recipharm Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Recipharm Recent Developments and Future Plans
2.7 Strides Shasun
2.7.1 Strides Shasun Details
2.7.2 Strides Shasun Major Business
2.7.3 Strides Shasun Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
2.7.4 Strides Shasun Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Strides Shasun Recent Developments and Future Plans
2.8 Piramal
2.8.1 Piramal Details
2.8.2 Piramal Major Business
2.8.3 Piramal Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
2.8.4 Piramal Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Piramal Recent Developments and Future Plans
2.9 Metrics
2.9.1 Metrics Details
2.9.2 Metrics Major Business
2.9.3 Metrics Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
2.9.4 Metrics Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Metrics Recent Developments and Future Plans
2.10 AMRI
2.10.1 AMRI Details
2.10.2 AMRI Major Business
2.10.3 AMRI Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
2.10.4 AMRI Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 AMRI Recent Developments and Future Plans
2.11 Famar
2.11.1 Famar Details
2.11.2 Famar Major Business
2.11.3 Famar Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
2.11.4 Famar Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Famar Recent Developments and Future Plans
2.12 WuXi AppTech
2.12.1 WuXi AppTech Details
2.12.2 WuXi AppTech Major Business
2.12.3 WuXi AppTech Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
2.12.4 WuXi AppTech Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 WuXi AppTech Recent Developments and Future Plans
2.13 Asymchem
2.13.1 Asymchem Details
2.13.2 Asymchem Major Business
2.13.3 Asymchem Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
2.13.4 Asymchem Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Asymchem Recent Developments and Future Plans
2.14 Porton
2.14.1 Porton Details
2.14.2 Porton Major Business
2.14.3 Porton Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
2.14.4 Porton Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Porton Recent Developments and Future Plans
2.15 Amatsigroup
2.15.1 Amatsigroup Details
2.15.2 Amatsigroup Major Business
2.15.3 Amatsigroup Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
2.15.4 Amatsigroup Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Amatsigroup Recent Developments and Future Plans
2.16 AcuraBio
2.16.1 AcuraBio Details
2.16.2 AcuraBio Major Business
2.16.3 AcuraBio Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
2.16.4 AcuraBio Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 AcuraBio Recent Developments and Future Plans
2.17 Moravek
2.17.1 Moravek Details
2.17.2 Moravek Major Business
2.17.3 Moravek Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
2.17.4 Moravek Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Moravek Recent Developments and Future Plans
2.18 Ascendia Pharmaceuticals
2.18.1 Ascendia Pharmaceuticals Details
2.18.2 Ascendia Pharmaceuticals Major Business
2.18.3 Ascendia Pharmaceuticals Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
2.18.4 Ascendia Pharmaceuticals Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Ascendia Pharmaceuticals Recent Developments and Future Plans
2.19 Ardena
2.19.1 Ardena Details
2.19.2 Ardena Major Business
2.19.3 Ardena Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
2.19.4 Ardena Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 Ardena Recent Developments and Future Plans
2.20 CPL
2.20.1 CPL Details
2.20.2 CPL Major Business
2.20.3 CPL Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
2.20.4 CPL Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
2.20.5 CPL Recent Developments and Future Plans
2.21 Arranta Bio
2.21.1 Arranta Bio Details
2.21.2 Arranta Bio Major Business
2.21.3 Arranta Bio Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
2.21.4 Arranta Bio Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
2.21.5 Arranta Bio Recent Developments and Future Plans
2.22 UPM Pharmaceuticals
2.22.1 UPM Pharmaceuticals Details
2.22.2 UPM Pharmaceuticals Major Business
2.22.3 UPM Pharmaceuticals Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
2.22.4 UPM Pharmaceuticals Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
2.22.5 UPM Pharmaceuticals Recent Developments and Future Plans
2.23 FUJIFILM Diosynth Biotechnologies
2.23.1 FUJIFILM Diosynth Biotechnologies Details
2.23.2 FUJIFILM Diosynth Biotechnologies Major Business
2.23.3 FUJIFILM Diosynth Biotechnologies Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
2.23.4 FUJIFILM Diosynth Biotechnologies Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
2.23.5 FUJIFILM Diosynth Biotechnologies Recent Developments and Future Plans
2.24 Groupe Parima
2.24.1 Groupe Parima Details
2.24.2 Groupe Parima Major Business
2.24.3 Groupe Parima Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
2.24.4 Groupe Parima Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
2.24.5 Groupe Parima Recent Developments and Future Plans
2.25 TBD Pharmatech
2.25.1 TBD Pharmatech Details
2.25.2 TBD Pharmatech Major Business
2.25.3 TBD Pharmatech Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
2.25.4 TBD Pharmatech Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
2.25.5 TBD Pharmatech Recent Developments and Future Plans
2.26 Avid Bioservices
2.26.1 Avid Bioservices Details
2.26.2 Avid Bioservices Major Business
2.26.3 Avid Bioservices Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
2.26.4 Avid Bioservices Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
2.26.5 Avid Bioservices Recent Developments and Future Plans
2.27 Vetter Pharma
2.27.1 Vetter Pharma Details
2.27.2 Vetter Pharma Major Business
2.27.3 Vetter Pharma Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
2.27.4 Vetter Pharma Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
2.27.5 Vetter Pharma Recent Developments and Future Plans
2.28 NextPharma
2.28.1 NextPharma Details
2.28.2 NextPharma Major Business
2.28.3 NextPharma Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
2.28.4 NextPharma Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
2.28.5 NextPharma Recent Developments and Future Plans
2.29 Alcami
2.29.1 Alcami Details
2.29.2 Alcami Major Business
2.29.3 Alcami Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
2.29.4 Alcami Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
2.29.5 Alcami Recent Developments and Future Plans
2.30 NerPharMa
2.30.1 NerPharMa Details
2.30.2 NerPharMa Major Business
2.30.3 NerPharMa Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
2.30.4 NerPharMa Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
2.30.5 NerPharMa Recent Developments and Future Plans
2.31 Vetio
2.31.1 Vetio Details
2.31.2 Vetio Major Business
2.31.3 Vetio Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
2.31.4 Vetio Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
2.31.5 Vetio Recent Developments and Future Plans
2.32 Societal CDMO
2.32.1 Societal CDMO Details
2.32.2 Societal CDMO Major Business
2.32.3 Societal CDMO Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
2.32.4 Societal CDMO Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
2.32.5 Societal CDMO Recent Developments and Future Plans
2.33 ten23 health
2.33.1 ten23 health Details
2.33.2 ten23 health Major Business
2.33.3 ten23 health Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
2.33.4 ten23 health Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
2.33.5 ten23 health Recent Developments and Future Plans
2.34 Piramal Pharma Solutions
2.34.1 Piramal Pharma Solutions Details
2.34.2 Piramal Pharma Solutions Major Business
2.34.3 Piramal Pharma Solutions Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
2.34.4 Piramal Pharma Solutions Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
2.34.5 Piramal Pharma Solutions Recent Developments and Future Plans
2.35 MedPharm
2.35.1 MedPharm Details
2.35.2 MedPharm Major Business
2.35.3 MedPharm Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
2.35.4 MedPharm Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
2.35.5 MedPharm Recent Developments and Future Plans
2.36 Lundbeck
2.36.1 Lundbeck Details
2.36.2 Lundbeck Major Business
2.36.3 Lundbeck Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
2.36.4 Lundbeck Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
2.36.5 Lundbeck Recent Developments and Future Plans
2.37 AGC Pharma Chemicals
2.37.1 AGC Pharma Chemicals Details
2.37.2 AGC Pharma Chemicals Major Business
2.37.3 AGC Pharma Chemicals Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
2.37.4 AGC Pharma Chemicals Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
2.37.5 AGC Pharma Chemicals Recent Developments and Future Plans
2.38 BioVectra
2.38.1 BioVectra Details
2.38.2 BioVectra Major Business
2.38.3 BioVectra Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
2.38.4 BioVectra Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
2.38.5 BioVectra Recent Developments and Future Plans
2.39 Pfizer CentreOne
2.39.1 Pfizer CentreOne Details
2.39.2 Pfizer CentreOne Major Business
2.39.3 Pfizer CentreOne Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
2.39.4 Pfizer CentreOne Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
2.39.5 Pfizer CentreOne Recent Developments and Future Plans
2.40 Jubilant Biosys
2.40.1 Jubilant Biosys Details
2.40.2 Jubilant Biosys Major Business
2.40.3 Jubilant Biosys Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
2.40.4 Jubilant Biosys Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue, Gross Margin and Market Share (2018-2023)
2.40.5 Jubilant Biosys Recent Developments and Future Plans
2.41 SEIKAGAKU CORPORATION
2.42 Mikart
2.43 Adare Pharma Solutions
2.44 Fermion
2.45 Samsung Biologics
2.46 Siegfried Holdings
2.47 Boehringer Ingelheim
2.48 Jubilant Pharmova Limited
2.49 Fareva SA
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) by Company Revenue
3.2.2 Top 3 Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Players Market Share in 2022
3.2.3 Top 6 Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Players Market Share in 2022
3.3 Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market: Overall Company Footprint Analysis
3.3.1 Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market: Region Footprint
3.3.2 Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market: Company Product Type Footprint
3.3.3 Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value and Market Share by Type (2018-2023)
4.2 Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value Market Share by Application (2018-2023)
5.2 Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Type (2018-2029)
6.2 North America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Application (2018-2029)
6.3 North America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Country
6.3.1 North America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Country (2018-2029)
6.3.2 United States Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size and Forecast (2018-2029)
6.3.3 Canada Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size and Forecast (2018-2029)
6.3.4 Mexico Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Type (2018-2029)
7.2 Europe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Application (2018-2029)
7.3 Europe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Country
7.3.1 Europe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Country (2018-2029)
7.3.2 Germany Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size and Forecast (2018-2029)
7.3.3 France Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size and Forecast (2018-2029)
7.3.5 Russia Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size and Forecast (2018-2029)
7.3.6 Italy Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Region
8.3.1 Asia-Pacific Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Region (2018-2029)
8.3.2 China Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size and Forecast (2018-2029)
8.3.3 Japan Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size and Forecast (2018-2029)
8.3.4 South Korea Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size and Forecast (2018-2029)
8.3.5 India Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size and Forecast (2018-2029)
8.3.7 Australia Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Type (2018-2029)
9.2 South America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Application (2018-2029)
9.3 South America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Country
9.3.1 South America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Country (2018-2029)
9.3.2 Brazil Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size and Forecast (2018-2029)
9.3.3 Argentina Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size by Country
10.3.1 Middle East & Africa Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Country (2018-2029)
10.3.2 Turkey Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size and Forecast (2018-2029)
10.3.4 UAE Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Drivers
11.2 Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market Restraints
11.3 Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Pharmaceutical CDMO (Phar
LIST OF TABLES
Table 1. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Lonza Company Information, Head Office, and Major Competitors
Table 6. Lonza Major Business
Table 7. Lonza Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
Table 8. Lonza Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Lonza Recent Developments and Future Plans
Table 10. Catalent Company Information, Head Office, and Major Competitors
Table 11. Catalent Major Business
Table 12. Catalent Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
Table 13. Catalent Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Catalent Recent Developments and Future Plans
Table 15. Patheon (Thermo Fisher Scientific) Company Information, Head Office, and Major Competitors
Table 16. Patheon (Thermo Fisher Scientific) Major Business
Table 17. Patheon (Thermo Fisher Scientific) Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
Table 18. Patheon (Thermo Fisher Scientific) Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Patheon (Thermo Fisher Scientific) Recent Developments and Future Plans
Table 20. Aenova Company Information, Head Office, and Major Competitors
Table 21. Aenova Major Business
Table 22. Aenova Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
Table 23. Aenova Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Aenova Recent Developments and Future Plans
Table 25. Siegfried Company Information, Head Office, and Major Competitors
Table 26. Siegfried Major Business
Table 27. Siegfried Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
Table 28. Siegfried Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Siegfried Recent Developments and Future Plans
Table 30. Recipharm Company Information, Head Office, and Major Competitors
Table 31. Recipharm Major Business
Table 32. Recipharm Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
Table 33. Recipharm Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Recipharm Recent Developments and Future Plans
Table 35. Strides Shasun Company Information, Head Office, and Major Competitors
Table 36. Strides Shasun Major Business
Table 37. Strides Shasun Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
Table 38. Strides Shasun Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Strides Shasun Recent Developments and Future Plans
Table 40. Piramal Company Information, Head Office, and Major Competitors
Table 41. Piramal Major Business
Table 42. Piramal Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
Table 43. Piramal Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Piramal Recent Developments and Future Plans
Table 45. Metrics Company Information, Head Office, and Major Competitors
Table 46. Metrics Major Business
Table 47. Metrics Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
Table 48. Metrics Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Metrics Recent Developments and Future Plans
Table 50. AMRI Company Information, Head Office, and Major Competitors
Table 51. AMRI Major Business
Table 52. AMRI Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
Table 53. AMRI Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. AMRI Recent Developments and Future Plans
Table 55. Famar Company Information, Head Office, and Major Competitors
Table 56. Famar Major Business
Table 57. Famar Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
Table 58. Famar Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Famar Recent Developments and Future Plans
Table 60. WuXi AppTech Company Information, Head Office, and Major Competitors
Table 61. WuXi AppTech Major Business
Table 62. WuXi AppTech Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
Table 63. WuXi AppTech Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. WuXi AppTech Recent Developments and Future Plans
Table 65. Asymchem Company Information, Head Office, and Major Competitors
Table 66. Asymchem Major Business
Table 67. Asymchem Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
Table 68. Asymchem Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Asymchem Recent Developments and Future Plans
Table 70. Porton Company Information, Head Office, and Major Competitors
Table 71. Porton Major Business
Table 72. Porton Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
Table 73. Porton Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Porton Recent Developments and Future Plans
Table 75. Amatsigroup Company Information, Head Office, and Major Competitors
Table 76. Amatsigroup Major Business
Table 77. Amatsigroup Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
Table 78. Amatsigroup Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Amatsigroup Recent Developments and Future Plans
Table 80. AcuraBio Company Information, Head Office, and Major Competitors
Table 81. AcuraBio Major Business
Table 82. AcuraBio Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
Table 83. AcuraBio Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. AcuraBio Recent Developments and Future Plans
Table 85. Moravek Company Information, Head Office, and Major Competitors
Table 86. Moravek Major Business
Table 87. Moravek Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
Table 88. Moravek Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Moravek Recent Developments and Future Plans
Table 90. Ascendia Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 91. Ascendia Pharmaceuticals Major Business
Table 92. Ascendia Pharmaceuticals Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
Table 93. Ascendia Pharmaceuticals Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 94. Ascendia Pharmaceuticals Recent Developments and Future Plans
Table 95. Ardena Company Information, Head Office, and Major Competitors
Table 96. Ardena Major Business
Table 97. Ardena Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
Table 98. Ardena Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 99. Ardena Recent Developments and Future Plans
Table 100. CPL Company Information, Head Office, and Major Competitors
Table 101. CPL Major Business
Table 102. CPL Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
Table 103. CPL Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 104. CPL Recent Developments and Future Plans
Table 105. Arranta Bio Company Information, Head Office, and Major Competitors
Table 106. Arranta Bio Major Business
Table 107. Arranta Bio Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
Table 108. Arranta Bio Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 109. Arranta Bio Recent Developments and Future Plans
Table 110. UPM Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 111. UPM Pharmaceuticals Major Business
Table 112. UPM Pharmaceuticals Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
Table 113. UPM Pharmaceuticals Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 114. UPM Pharmaceuticals Recent Developments and Future Plans
Table 115. FUJIFILM Diosynth Biotechnologies Company Information, Head Office, and Major Competitors
Table 116. FUJIFILM Diosynth Biotechnologies Major Business
Table 117. FUJIFILM Diosynth Biotechnologies Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
Table 118. FUJIFILM Diosynth Biotechnologies Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. FUJIFILM Diosynth Biotechnologies Recent Developments and Future Plans
Table 120. Groupe Parima Company Information, Head Office, and Major Competitors
Table 121. Groupe Parima Major Business
Table 122. Groupe Parima Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
Table 123. Groupe Parima Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 124. Groupe Parima Recent Developments and Future Plans
Table 125. TBD Pharmatech Company Information, Head Office, and Major Competitors
Table 126. TBD Pharmatech Major Business
Table 127. TBD Pharmatech Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
Table 128. TBD Pharmatech Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 129. TBD Pharmatech Recent Developments and Future Plans
Table 130. Avid Bioservices Company Information, Head Office, and Major Competitors
Table 131. Avid Bioservices Major Business
Table 132. Avid Bioservices Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
Table 133. Avid Bioservices Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 134. Avid Bioservices Recent Developments and Future Plans
Table 135. Vetter Pharma Company Information, Head Office, and Major Competitors
Table 136. Vetter Pharma Major Business
Table 137. Vetter Pharma Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
Table 138. Vetter Pharma Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 139. Vetter Pharma Recent Developments and Future Plans
Table 140. NextPharma Company Information, Head Office, and Major Competitors
Table 141. NextPharma Major Business
Table 142. NextPharma Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
Table 143. NextPharma Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 144. NextPharma Recent Developments and Future Plans
Table 145. Alcami Company Information, Head Office, and Major Competitors
Table 146. Alcami Major Business
Table 147. Alcami Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
Table 148. Alcami Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. Alcami Recent Developments and Future Plans
Table 150. NerPharMa Company Information, Head Office, and Major Competitors
Table 151. NerPharMa Major Business
Table 152. NerPharMa Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
Table 153. NerPharMa Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 154. NerPharMa Recent Developments and Future Plans
Table 155. Vetio Company Information, Head Office, and Major Competitors
Table 156. Vetio Major Business
Table 157. Vetio Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
Table 158. Vetio Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 159. Vetio Recent Developments and Future Plans
Table 160. Societal CDMO Company Information, Head Office, and Major Competitors
Table 161. Societal CDMO Major Business
Table 162. Societal CDMO Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
Table 163. Societal CDMO Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 164. Societal CDMO Recent Developments and Future Plans
Table 165. ten23 health Company Information, Head Office, and Major Competitors
Table 166. ten23 health Major Business
Table 167. ten23 health Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
Table 168. ten23 health Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 169. ten23 health Recent Developments and Future Plans
Table 170. Piramal Pharma Solutions Company Information, Head Office, and Major Competitors
Table 171. Piramal Pharma Solutions Major Business
Table 172. Piramal Pharma Solutions Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
Table 173. Piramal Pharma Solutions Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 174. Piramal Pharma Solutions Recent Developments and Future Plans
Table 175. MedPharm Company Information, Head Office, and Major Competitors
Table 176. MedPharm Major Business
Table 177. MedPharm Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
Table 178. MedPharm Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 179. MedPharm Recent Developments and Future Plans
Table 180. Lundbeck Company Information, Head Office, and Major Competitors
Table 181. Lundbeck Major Business
Table 182. Lundbeck Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
Table 183. Lundbeck Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 184. Lundbeck Recent Developments and Future Plans
Table 185. AGC Pharma Chemicals Company Information, Head Office, and Major Competitors
Table 186. AGC Pharma Chemicals Major Business
Table 187. AGC Pharma Chemicals Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
Table 188. AGC Pharma Chemicals Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 189. AGC Pharma Chemicals Recent Developments and Future Plans
Table 190. BioVectra Company Information, Head Office, and Major Competitors
Table 191. BioVectra Major Business
Table 192. BioVectra Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
Table 193. BioVectra Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 194. BioVectra Recent Developments and Future Plans
Table 195. Pfizer CentreOne Company Information, Head Office, and Major Competitors
Table 196. Pfizer CentreOne Major Business
Table 197. Pfizer CentreOne Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
Table 198. Pfizer CentreOne Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 199. Pfizer CentreOne Recent Developments and Future Plans
Table 200. Jubilant Biosys Company Information, Head Office, and Major Competitors
Table 201. Jubilant Biosys Major Business
Table 202. Jubilant Biosys Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
Table 203. Jubilant Biosys Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 204. Jubilant Biosys Recent Developments and Future Plans
Table 205. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (USD Million) by Players (2018-2023)
Table 206. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue Share by Players (2018-2023)
Table 207. Breakdown of Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) by Company Type (Tier 1, Tier 2, and Tier 3)
Table 208. Market Position of Players in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 209. Head Office of Key Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Players
Table 210. Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market: Company Product Type Footprint
Table 211. Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market: Company Product Application Footprint
Table 212. Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) New Market Entrants and Barriers to Market Entry
Table 213. Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Mergers, Acquisition, Agreements, and Collaborations
Table 214. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value (USD Million) by Type (2018-2023)
Table 215. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value Share by Type (2018-2023)
Table 216. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value Forecast by Type (2024-2029)
Table 217. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Application (2018-2023)
Table 218. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value Forecast by Application (2024-2029)
Table 219. North America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Type (2018-2023) & (USD Million)
Table 220. North America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Type (2024-2029) & (USD Million)
Table 221. North America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Application (2018-2023) & (USD Million)
Table 222. North America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Application (2024-2029) & (USD Million)
Table 223. North America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Country (2018-2023) & (USD Million)
Table 224. North America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Country (2024-2029) & (USD Million)
Table 225. Europe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Type (2018-2023) & (USD Million)
Table 226. Europe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Type (2024-2029) & (USD Million)
Table 227. Europe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Application (2018-2023) & (USD Million)
Table 228. Europe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Application (2024-2029) & (USD Million)
Table 229. Europe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Country (2018-2023) & (USD Million)
Table 230. Europe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Country (2024-2029) & (USD Million)
Table 231. Asia-Pacific Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Type (2018-2023) & (USD Million)
Table 232. Asia-Pacific Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Type (2024-2029) & (USD Million)
Table 233. Asia-Pacific Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Application (2018-2023) & (USD Million)
Table 234. Asia-Pacific Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Application (2024-2029) & (USD Million)
Table 235. Asia-Pacific Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Region (2018-2023) & (USD Million)
Table 236. Asia-Pacific Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Region (2024-2029) & (USD Million)
Table 237. South America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Type (2018-2023) & (USD Million)
Table 238. South America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Type (2024-2029) & (USD Million)
Table 239. South America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Application (2018-2023) & (USD Million)
Table 240. South America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Application (2024-2029) & (USD Million)
Table 241. South America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Country (2018-2023) & (USD Million)
Table 242. South America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Country (2024-2029) & (USD Million)
Table 243. Middle East & Africa Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Type (2018-2023) & (USD Million)
Table 244. Middle East & Africa Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Type (2024-2029) & (USD Million)
Table 245. Middle East & Africa Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Application (2018-2023) & (USD Million)
Table 246. Middle East & Africa Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Application (2024-2029) & (USD Million)
Table 247. Middle East & Africa Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Country (2018-2023) & (USD Million)
Table 248. Middle East & Africa Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Country (2024-2029) & (USD Million)
Table 249. Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Raw Material
Table 250. Key Suppliers of Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Raw Materials
Table 1. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Lonza Company Information, Head Office, and Major Competitors
Table 6. Lonza Major Business
Table 7. Lonza Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
Table 8. Lonza Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Lonza Recent Developments and Future Plans
Table 10. Catalent Company Information, Head Office, and Major Competitors
Table 11. Catalent Major Business
Table 12. Catalent Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
Table 13. Catalent Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Catalent Recent Developments and Future Plans
Table 15. Patheon (Thermo Fisher Scientific) Company Information, Head Office, and Major Competitors
Table 16. Patheon (Thermo Fisher Scientific) Major Business
Table 17. Patheon (Thermo Fisher Scientific) Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
Table 18. Patheon (Thermo Fisher Scientific) Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Patheon (Thermo Fisher Scientific) Recent Developments and Future Plans
Table 20. Aenova Company Information, Head Office, and Major Competitors
Table 21. Aenova Major Business
Table 22. Aenova Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
Table 23. Aenova Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Aenova Recent Developments and Future Plans
Table 25. Siegfried Company Information, Head Office, and Major Competitors
Table 26. Siegfried Major Business
Table 27. Siegfried Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
Table 28. Siegfried Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Siegfried Recent Developments and Future Plans
Table 30. Recipharm Company Information, Head Office, and Major Competitors
Table 31. Recipharm Major Business
Table 32. Recipharm Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
Table 33. Recipharm Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Recipharm Recent Developments and Future Plans
Table 35. Strides Shasun Company Information, Head Office, and Major Competitors
Table 36. Strides Shasun Major Business
Table 37. Strides Shasun Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
Table 38. Strides Shasun Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Strides Shasun Recent Developments and Future Plans
Table 40. Piramal Company Information, Head Office, and Major Competitors
Table 41. Piramal Major Business
Table 42. Piramal Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
Table 43. Piramal Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Piramal Recent Developments and Future Plans
Table 45. Metrics Company Information, Head Office, and Major Competitors
Table 46. Metrics Major Business
Table 47. Metrics Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
Table 48. Metrics Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Metrics Recent Developments and Future Plans
Table 50. AMRI Company Information, Head Office, and Major Competitors
Table 51. AMRI Major Business
Table 52. AMRI Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
Table 53. AMRI Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. AMRI Recent Developments and Future Plans
Table 55. Famar Company Information, Head Office, and Major Competitors
Table 56. Famar Major Business
Table 57. Famar Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
Table 58. Famar Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Famar Recent Developments and Future Plans
Table 60. WuXi AppTech Company Information, Head Office, and Major Competitors
Table 61. WuXi AppTech Major Business
Table 62. WuXi AppTech Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
Table 63. WuXi AppTech Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. WuXi AppTech Recent Developments and Future Plans
Table 65. Asymchem Company Information, Head Office, and Major Competitors
Table 66. Asymchem Major Business
Table 67. Asymchem Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
Table 68. Asymchem Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Asymchem Recent Developments and Future Plans
Table 70. Porton Company Information, Head Office, and Major Competitors
Table 71. Porton Major Business
Table 72. Porton Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
Table 73. Porton Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Porton Recent Developments and Future Plans
Table 75. Amatsigroup Company Information, Head Office, and Major Competitors
Table 76. Amatsigroup Major Business
Table 77. Amatsigroup Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
Table 78. Amatsigroup Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Amatsigroup Recent Developments and Future Plans
Table 80. AcuraBio Company Information, Head Office, and Major Competitors
Table 81. AcuraBio Major Business
Table 82. AcuraBio Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
Table 83. AcuraBio Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. AcuraBio Recent Developments and Future Plans
Table 85. Moravek Company Information, Head Office, and Major Competitors
Table 86. Moravek Major Business
Table 87. Moravek Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
Table 88. Moravek Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Moravek Recent Developments and Future Plans
Table 90. Ascendia Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 91. Ascendia Pharmaceuticals Major Business
Table 92. Ascendia Pharmaceuticals Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
Table 93. Ascendia Pharmaceuticals Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 94. Ascendia Pharmaceuticals Recent Developments and Future Plans
Table 95. Ardena Company Information, Head Office, and Major Competitors
Table 96. Ardena Major Business
Table 97. Ardena Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
Table 98. Ardena Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 99. Ardena Recent Developments and Future Plans
Table 100. CPL Company Information, Head Office, and Major Competitors
Table 101. CPL Major Business
Table 102. CPL Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
Table 103. CPL Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 104. CPL Recent Developments and Future Plans
Table 105. Arranta Bio Company Information, Head Office, and Major Competitors
Table 106. Arranta Bio Major Business
Table 107. Arranta Bio Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
Table 108. Arranta Bio Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 109. Arranta Bio Recent Developments and Future Plans
Table 110. UPM Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 111. UPM Pharmaceuticals Major Business
Table 112. UPM Pharmaceuticals Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
Table 113. UPM Pharmaceuticals Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 114. UPM Pharmaceuticals Recent Developments and Future Plans
Table 115. FUJIFILM Diosynth Biotechnologies Company Information, Head Office, and Major Competitors
Table 116. FUJIFILM Diosynth Biotechnologies Major Business
Table 117. FUJIFILM Diosynth Biotechnologies Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
Table 118. FUJIFILM Diosynth Biotechnologies Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. FUJIFILM Diosynth Biotechnologies Recent Developments and Future Plans
Table 120. Groupe Parima Company Information, Head Office, and Major Competitors
Table 121. Groupe Parima Major Business
Table 122. Groupe Parima Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
Table 123. Groupe Parima Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 124. Groupe Parima Recent Developments and Future Plans
Table 125. TBD Pharmatech Company Information, Head Office, and Major Competitors
Table 126. TBD Pharmatech Major Business
Table 127. TBD Pharmatech Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
Table 128. TBD Pharmatech Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 129. TBD Pharmatech Recent Developments and Future Plans
Table 130. Avid Bioservices Company Information, Head Office, and Major Competitors
Table 131. Avid Bioservices Major Business
Table 132. Avid Bioservices Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
Table 133. Avid Bioservices Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 134. Avid Bioservices Recent Developments and Future Plans
Table 135. Vetter Pharma Company Information, Head Office, and Major Competitors
Table 136. Vetter Pharma Major Business
Table 137. Vetter Pharma Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
Table 138. Vetter Pharma Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 139. Vetter Pharma Recent Developments and Future Plans
Table 140. NextPharma Company Information, Head Office, and Major Competitors
Table 141. NextPharma Major Business
Table 142. NextPharma Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
Table 143. NextPharma Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 144. NextPharma Recent Developments and Future Plans
Table 145. Alcami Company Information, Head Office, and Major Competitors
Table 146. Alcami Major Business
Table 147. Alcami Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
Table 148. Alcami Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. Alcami Recent Developments and Future Plans
Table 150. NerPharMa Company Information, Head Office, and Major Competitors
Table 151. NerPharMa Major Business
Table 152. NerPharMa Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
Table 153. NerPharMa Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 154. NerPharMa Recent Developments and Future Plans
Table 155. Vetio Company Information, Head Office, and Major Competitors
Table 156. Vetio Major Business
Table 157. Vetio Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
Table 158. Vetio Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 159. Vetio Recent Developments and Future Plans
Table 160. Societal CDMO Company Information, Head Office, and Major Competitors
Table 161. Societal CDMO Major Business
Table 162. Societal CDMO Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
Table 163. Societal CDMO Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 164. Societal CDMO Recent Developments and Future Plans
Table 165. ten23 health Company Information, Head Office, and Major Competitors
Table 166. ten23 health Major Business
Table 167. ten23 health Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
Table 168. ten23 health Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 169. ten23 health Recent Developments and Future Plans
Table 170. Piramal Pharma Solutions Company Information, Head Office, and Major Competitors
Table 171. Piramal Pharma Solutions Major Business
Table 172. Piramal Pharma Solutions Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
Table 173. Piramal Pharma Solutions Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 174. Piramal Pharma Solutions Recent Developments and Future Plans
Table 175. MedPharm Company Information, Head Office, and Major Competitors
Table 176. MedPharm Major Business
Table 177. MedPharm Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
Table 178. MedPharm Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 179. MedPharm Recent Developments and Future Plans
Table 180. Lundbeck Company Information, Head Office, and Major Competitors
Table 181. Lundbeck Major Business
Table 182. Lundbeck Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
Table 183. Lundbeck Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 184. Lundbeck Recent Developments and Future Plans
Table 185. AGC Pharma Chemicals Company Information, Head Office, and Major Competitors
Table 186. AGC Pharma Chemicals Major Business
Table 187. AGC Pharma Chemicals Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
Table 188. AGC Pharma Chemicals Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 189. AGC Pharma Chemicals Recent Developments and Future Plans
Table 190. BioVectra Company Information, Head Office, and Major Competitors
Table 191. BioVectra Major Business
Table 192. BioVectra Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
Table 193. BioVectra Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 194. BioVectra Recent Developments and Future Plans
Table 195. Pfizer CentreOne Company Information, Head Office, and Major Competitors
Table 196. Pfizer CentreOne Major Business
Table 197. Pfizer CentreOne Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
Table 198. Pfizer CentreOne Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 199. Pfizer CentreOne Recent Developments and Future Plans
Table 200. Jubilant Biosys Company Information, Head Office, and Major Competitors
Table 201. Jubilant Biosys Major Business
Table 202. Jubilant Biosys Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Product and Solutions
Table 203. Jubilant Biosys Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 204. Jubilant Biosys Recent Developments and Future Plans
Table 205. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue (USD Million) by Players (2018-2023)
Table 206. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Revenue Share by Players (2018-2023)
Table 207. Breakdown of Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) by Company Type (Tier 1, Tier 2, and Tier 3)
Table 208. Market Position of Players in Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 209. Head Office of Key Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Players
Table 210. Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market: Company Product Type Footprint
Table 211. Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Market: Company Product Application Footprint
Table 212. Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) New Market Entrants and Barriers to Market Entry
Table 213. Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Mergers, Acquisition, Agreements, and Collaborations
Table 214. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value (USD Million) by Type (2018-2023)
Table 215. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value Share by Type (2018-2023)
Table 216. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value Forecast by Type (2024-2029)
Table 217. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Application (2018-2023)
Table 218. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value Forecast by Application (2024-2029)
Table 219. North America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Type (2018-2023) & (USD Million)
Table 220. North America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Type (2024-2029) & (USD Million)
Table 221. North America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Application (2018-2023) & (USD Million)
Table 222. North America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Application (2024-2029) & (USD Million)
Table 223. North America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Country (2018-2023) & (USD Million)
Table 224. North America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Country (2024-2029) & (USD Million)
Table 225. Europe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Type (2018-2023) & (USD Million)
Table 226. Europe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Type (2024-2029) & (USD Million)
Table 227. Europe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Application (2018-2023) & (USD Million)
Table 228. Europe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Application (2024-2029) & (USD Million)
Table 229. Europe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Country (2018-2023) & (USD Million)
Table 230. Europe Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Country (2024-2029) & (USD Million)
Table 231. Asia-Pacific Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Type (2018-2023) & (USD Million)
Table 232. Asia-Pacific Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Type (2024-2029) & (USD Million)
Table 233. Asia-Pacific Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Application (2018-2023) & (USD Million)
Table 234. Asia-Pacific Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Application (2024-2029) & (USD Million)
Table 235. Asia-Pacific Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Region (2018-2023) & (USD Million)
Table 236. Asia-Pacific Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Region (2024-2029) & (USD Million)
Table 237. South America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Type (2018-2023) & (USD Million)
Table 238. South America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Type (2024-2029) & (USD Million)
Table 239. South America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Application (2018-2023) & (USD Million)
Table 240. South America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Application (2024-2029) & (USD Million)
Table 241. South America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Country (2018-2023) & (USD Million)
Table 242. South America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Country (2024-2029) & (USD Million)
Table 243. Middle East & Africa Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Type (2018-2023) & (USD Million)
Table 244. Middle East & Africa Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Type (2024-2029) & (USD Million)
Table 245. Middle East & Africa Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Application (2018-2023) & (USD Million)
Table 246. Middle East & Africa Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Application (2024-2029) & (USD Million)
Table 247. Middle East & Africa Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Country (2018-2023) & (USD Million)
Table 248. Middle East & Africa Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Country (2024-2029) & (USD Million)
Table 249. Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Raw Material
Table 250. Key Suppliers of Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Raw Materials
LIST OF FIGURES
s
Figure 1. Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Picture
Figure 2. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value Market Share by Type in 2022
Figure 4. Intermediate CDMO
Figure 5. API CDMO
Figure 6. Formulation CDMO
Figure 7. Protein CDMO
Figure 8. Gene Therapy CDMO
Figure 9. Cell Therapy CDMO
Figure 10. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 11. Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value Market Share by Application in 2022
Figure 12. Pharmaceutical Company Picture
Figure 13. Biotechnology Company Picture
Figure 14. Generic Company Picture
Figure 15. Others Picture
Figure 16. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 17. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 18. Global Market Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 19. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value Market Share by Region (2018-2029)
Figure 20. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value Market Share by Region in 2022
Figure 21. North America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value (2018-2029) & (US
s
Figure 1. Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Picture
Figure 2. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value Market Share by Type in 2022
Figure 4. Intermediate CDMO
Figure 5. API CDMO
Figure 6. Formulation CDMO
Figure 7. Protein CDMO
Figure 8. Gene Therapy CDMO
Figure 9. Cell Therapy CDMO
Figure 10. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 11. Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value Market Share by Application in 2022
Figure 12. Pharmaceutical Company Picture
Figure 13. Biotechnology Company Picture
Figure 14. Generic Company Picture
Figure 15. Others Picture
Figure 16. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 17. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 18. Global Market Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 19. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value Market Share by Region (2018-2029)
Figure 20. Global Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value Market Share by Region in 2022
Figure 21. North America Pharmaceutical CDMO (Pharmaceutical Contract Development and Manufacturing Organization) Consumption Value (2018-2029) & (US
